IPCA Laboratories Ltd
NSE:IPCALAB

Watchlist Manager
IPCA Laboratories Ltd Logo
IPCA Laboratories Ltd
NSE:IPCALAB
Watchlist
Price: 1 536.55 INR 2.11% Market Closed
Market Cap: 389.8B INR
Have any thoughts about
IPCA Laboratories Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
IPCA Laboratories Ltd

Current Assets 55.4B
Cash & Short-Term Investments 7.1B
Receivables 19.3B
Other Current Assets 29.1B
Non-Current Assets 55.6B
Long-Term Investments 3B
PP&E 46.6B
Intangibles 2.3B
Other Non-Current Assets 3.6B
Current Liabilities 23.6B
Accounts Payable 7.8B
Accrued Liabilities 949.4m
Short-Term Debt 5.6B
Other Current Liabilities 9.3B
Non-Current Liabilities 24.1B
Long-Term Debt 6.2B
Other Non-Current Liabilities 17.9B

Balance Sheet
IPCA Laboratories Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
630
243
275
276
260
584
1 660
2 752
12 579
2 089
Cash
613
227
262
262
254
547
1 060
722
917
1 388
Cash Equivalents
17
16
13
14
6
37
600
2 030
11 662
701
Short-Term Investments
963
1 447
1 155
1 911
3 456
3 598
6 028
10 949
9 295
6 364
Total Receivables
8 029
5 862
6 736
8 160
8 902
10 783
10 325
11 547
11 889
19 271
Accounts Receivables
6 386
4 502
5 120
6 063
6 840
8 993
8 157
9 180
10 263
17 044
Other Receivables
1 643
1 360
1 616
2 097
2 062
1 790
2 168
2 367
1 626
2 227
Inventory
9 343
8 420
8 884
8 875
10 962
13 384
16 106
18 897
17 732
25 120
Other Current Assets
383
249
291
234
199
208
251
428
398
2 545
Total Current Assets
19 348
16 219
17 340
19 455
23 778
28 557
34 370
44 572
51 893
55 389
PP&E Net
19 532
20 355
19 755
18 954
17 826
19 933
21 465
25 026
26 946
46 632
PP&E Gross
19 532
20 355
19 755
18 954
17 826
19 933
21 465
25 026
26 946
46 632
Accumulated Depreciation
7 135
1 536
3 145
4 788
6 441
8 185
9 938
11 891
14 306
22 535
Intangible Assets
536
602
552
834
1 770
1 363
1 142
1 672
1 591
1 426
Goodwill
472
472
472
472
472
624
466
542
381
906
Note Receivable
954
816
1 114
1 160
1 269
1 307
1 887
1 731
1 530
1 210
Long-Term Investments
193
258
222
175
301
713
1 114
2 699
3 027
3 036
Other Long-Term Assets
213
195
140
123
93
101
240
148
897
2 413
Other Assets
472
472
472
472
472
624
466
542
381
906
Total Assets
41 248
N/A
38 917
-6%
39 595
+2%
41 173
+4%
45 507
+11%
52 598
+16%
60 684
+15%
76 389
+26%
86 264
+13%
111 013
+29%
Liabilities
Accounts Payable
3 060
4 211
4 577
4 235
5 243
6 099
6 649
5 577
5 251
7 761
Accrued Liabilities
429
253
244
199
176
285
300
527
379
949
Short-Term Debt
6 433
1 849
1 773
2 390
2 097
3 110
1 766
3 678
6 618
5 592
Current Portion of Long-Term Debt
1 059
1 981
1 867
1 545
1 144
738
714
327
1 506
2 588
Other Current Liabilities
1 536
1 406
1 098
1 707
2 315
3 033
2 177
4 550
4 305
6 666
Total Current Liabilities
12 517
9 700
9 559
10 076
10 975
13 264
11 605
14 659
18 058
23 556
Long-Term Debt
4 987
4 843
3 517
2 340
1 409
1 160
174
4 067
6 689
6 203
Deferred Income Tax
1 584
1 565
1 705
1 597
1 476
1 418
1 336
1 526
1 892
3 105
Minority Interest
0
0
0
0
155
136
145
769
733
13 948
Other Liabilities
194
218
261
274
268
345
407
448
473
878
Total Liabilities
19 282
N/A
16 325
-15%
15 043
-8%
14 287
-5%
14 283
0%
16 324
+14%
13 667
-16%
21 469
+57%
27 844
+30%
47 691
+71%
Equity
Common Stock
252
252
252
252
253
253
254
254
254
254
Retained Earnings
21 137
21 936
23 859
26 119
30 431
35 382
45 657
53 540
57 219
62 189
Additional Paid In Capital
440
440
440
440
489
489
965
965
965
965
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
65
Other Equity
136
37
1
75
51
151
141
161
18
21
Total Equity
21 965
N/A
22 592
+3%
24 553
+9%
26 886
+10%
31 224
+16%
36 275
+16%
47 017
+30%
54 920
+17%
58 420
+6%
63 322
+8%
Total Liabilities & Equity
41 248
N/A
38 917
-6%
39 595
+2%
41 173
+4%
45 507
+11%
52 598
+16%
60 684
+15%
76 389
+26%
86 264
+13%
111 013
+29%
Shares Outstanding
Common Shares Outstanding
252
252
252
252
253
253
254
254
254
254

See Also

Discover More